We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.81%
5 Year Est. Return
+48.65%
10 Year Est. Return
–
AUM
$304M
AUM Growth
+$17.2M
Cap. Flow
-$1.31M
Cap. Flow %
-0.43%
Top 10 Hldgs %
39.76%
Holding
80
New
1
Increased
8
Reduced
38
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.66M
2
NVS icon
Novartis
NVS
+$488K
3
GE icon
GE Aerospace
GE
+$177K
4
CVS icon
CVS Health
CVS
+$167K
5
SLB icon
SLB Ltd
SLB
+$90.5K

Top Sells

Rank Stock Value
1
BRKR icon
Bruker
BRKR
+$923K
2
SVU
SUPERVALU Inc.
SVU
+$708K
3
LVLT
Level 3 Communications Inc
LVLT
+$282K
4
DO
Diamond Offshore Drilling
DO
+$261K
5
INTC icon
Intel
INTC
+$140K

Sector Composition

Rank Sector Weight
1 Healthcare 27.94%
2 Industrials 23%
3 Technology 16.75%
4 Energy 9.09%
5 Consumer Staples 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAT icon
51
Caterpillar
CAT
$395B
$1.5M 0.49%
9,488
-635
-6% -$88.1K
RIG icon
52
Transocean
RIG
$5.71B
$1.38M 0.45%
128,893
-6,098
-5% -$63.3K
DVN icon
53
Devon Energy
DVN
$49.7B
$1.34M 0.44%
32,300
-175
-0.5% -$6.62K
USB icon
54
US Bancorp
USB
$99.4B
$1.29M 0.42%
24,037
– –
FLOW
55
DELISTED
SPX FLOW, Inc.
FLOW
$1.27M 0.42%
26,722
– –
SPXC icon
56
SPX Corp
SPXC
$10.7B
$1.18M 0.39%
37,727
– –
VZ icon
57
Verizon
VZ
$195B
$1.02M 0.33%
19,186
+540
+3% +$26.6K
T icon
58
AT&T
T
$162B
$1.01M 0.33%
34,486
-265
-0.8% -$7.24K
BIVV
59
DELISTED
Bioverativ Inc. Common Stock
BIVV
$892K 0.29%
16,538
-100
-0.6% -$5.47K
BWA icon
60
BorgWarner
BWA
$13.5B
$741K 0.24%
16,481
-144
-0.9% -$6.66K
CDK
61
DELISTED
CDK Global, Inc.
CDK
$720K 0.24%
10,095
-85
-0.8% -$5.71K
JPM icon
62
JPMorgan Chase
JPM
$947B
$669K 0.22%
6,255
– –
MRK icon
63
Merck
MRK
$317B
$609K 0.2%
11,349
-314
-3% -$17.4K
TRV icon
64
Travelers Companies
TRV
$80.5B
$608K 0.2%
4,479
– –
BMY icon
65
Bristol-Myers Squibb
BMY
$131B
$588K 0.19%
9,600
– –
VREX icon
66
Varex Imaging
VREX
$516M
$536K 0.18%
13,350
-650
-5% -$23.4K
MRSH
67
Marsh
MRSH
$92.2B
$533K 0.18%
6,543
– –
AGN
68
DELISTED
Allergan plc
AGN
$482K 0.16%
2,946
– –
JCI icon
69
Johnson Controls International
JCI
$93.6B
$436K 0.14%
11,432
– –
RTX icon
70
RTX Corp
RTX
$301B
$408K 0.13%
5,085
– –
WST icon
71
West Pharmaceutical
WST
$24.5B
$386K 0.13%
3,907
-93
-2% -$9.12K
ING icon
72
ING
ING
$102B
$376K 0.12%
20,388
– –
ORCL icon
73
Oracle
ORCL
$413B
$374K 0.12%
7,900
– –
EW icon
74
Edwards Lifesciences
EW
$51.5B
$328K 0.11%
8,718
– –
CBT icon
75
Cabot Corp
CBT
$4.52B
$296K 0.1%
4,800
– –
1 2
3
4

Similar funds

CFS
Ceros Financial Services Rockville, Maryland $316M AUM
SVWA
Sound View Wealth Advisors Savannah, Georgia $319M AUM
SAS
Sarbit Advisory Services Winnipeg, Manitoba, Canada $294M AUM 0.68% 1-Year Est. Return
LYV
Live Your Vision West Conshohocken, Pennsylvania $330M AUM 2.28% 1-Year Est. Return
TAT
TD Ameritrade Trust Denver, Colorado $285M AUM 0.17% 1-Year Est. Return
NAP
New Amsterdam Partners New York $272M AUM 12.21% 1-Year Est. Return
OAMU
Ostrum Asset Management US New York $359M AUM
TCM
Tradition Capital Management Summit, New Jersey $369M AUM 6.72% 1-Year Est. Return

Thompson Rubinstein Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Rubinstein Investment Management held 80 positions worth $304M, up 6% from $287M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.8%. Thompson Rubinstein Investment Management opened 1 new position and exited 2, leaving the 80-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management's largest Q4 2017 buy was Celgene Corp: 14,732 shares worth $1.54M.
  • Thompson Rubinstein Investment Management added most to Novartis in Q4 2017, an estimated $488K increase.
  • Thompson Rubinstein Investment Management's biggest Q4 2017 reduction was Bruker, cutting an estimated $923K.
  • Thompson Rubinstein Investment Management fully exited SUPERVALU Inc. in Q4 2017, selling an estimated $708K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 40% of its $304M portfolio in Q4 2017.
  • Thompson Rubinstein Investment Management opened 1 new position and closed 2 in Q4 2017.
  • Thompson Rubinstein Investment Management's portfolio value rose 6% quarter-over-quarter to $304M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q4 2017, filed 17 Jan 2018.